Cost-effectiveness of angiotensin receptor blockers in patients with hypertension: A comparative analysis using clinical trial and observational data

被引：0
|
作者：
Boersma, C. [1 ]
Voors, A. A. [2 ]
Van den Berg, P. B. [1 ]
Visser, S. T. [1 ]
De Jong-van den Berg, L. T. [1 ]
Postma, M. J. [1 ]
机构：
[1] Univ Groningen, NL-9700 AB Groningen, Netherlands
[2] Univ Med Ctr, Groningen, Netherlands
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65453-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A417 / A417
页数：1
相关论文
共 50 条
  • [21] A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial
    Baker, Christine L.
    Pietri, Guilhem
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 67 - 74
  • [22] Comparative Effectiveness of Angiotensin Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) for the Risk of Dementia in Patients With Type 2 Diabetes Mellitus and Hypertension
    Mehta, Hemalkumar B.
    Mehta, Vinay
    Tsai, Chu-Lin
    Chen, Hua
    Aparasu, Rajender
    Johnson, Michael L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 427 - 427
  • [23] Updating Cost-Effectiveness of Stroke Thrombectomy in Patients With Large Core Ischemic Stroke Using 2023 Clinical Trial Data
    Kao, Szu-Yu Zoe
    Sangha, Kinpritma
    Sanmartin, Maria
    Siddiqui, Adnan H.
    Mocco, J. D.
    Hui, Ferdinand
    Hochrein, Patrick
    Sanelli, Pina C.
    Eusemann, Christian
    Turner, Raymond
    STROKE, 2024, 55
  • [24] Systematic review: Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension
    Matchar, David B.
    McCrory, Douglas C.
    Orlando, Lori A.
    Patel, Manesh R.
    Patel, Uptal D.
    Patwardhan, Meenal B.
    Powers, Benjamin
    Samsa, Gregory P.
    Gray, Rebecca N.
    ANNALS OF INTERNAL MEDICINE, 2008, 148 (01) : 16 - 29
  • [25] Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Among Chronic Kidney Disease Patients
    Zullo, Andrew R.
    Dahabreh, Issa J.
    Nelson, Jason
    Kent, David M.
    Crown, William H.
    Shah, Nilay D.
    Inker, Lesley A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 479 - 479
  • [26] USING COST-EFFECTIVENESS ANALYSIS TO DEFINE THE CLINICAL-SIGNIFICANCE OF EFFECTIVENESS RATES IN THE PLANNING STAGES OF A CLINICAL-TRIAL
    DETSKY, AS
    MEDICAL DECISION MAKING, 1983, 3 (03) : 356 - 356
  • [27] Cost-effectiveness of losartan in patients with hypertension and LVH: An economic evaluation of the LIFE trial
    Jonsson, B
    Carides, GW
    Burke, TA
    Dasbach, EJ
    Lindholm, L
    Dahlof, B
    JOURNAL OF HYPERTENSION, 2004, 22 : S289 - S290
  • [28] Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial)
    Michales, J. A.
    Campbell, W. B.
    Brazier, J. E.
    MacIntyre, J. B.
    Palfreyman, S. J.
    Ratcliffe, J.
    Rigby, K.
    HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (13) : III - +
  • [29] Bayesian cost-effectiveness analysis -: An example using the GUSTO trial
    Fryback, DG
    Chinnis, JO
    Ulvila, JW
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2001, 17 (01) : 83 - 97
  • [30] Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure
    Desai, Rishi J.
    Ashton, Carol M.
    Deswal, Anita
    Morgan, Robert O.
    Mehta, Hemalkumar B.
    Chen, Hua
    Aparasu, Rajender R.
    Johnson, Michael L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (03) : 233 - 240
12345